Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma.
Riccardi A, Mora O, Tinelli C, Valentini D, Brugnatelli S, Spanedda R, De Paoli A, Barbarano L, Di Stasi M, Giordano M, Delfini C, Nicoletti G, Bergonzi C, Rinaldi E, Piccinini L, Ascari E. Riccardi A, et al. Br J Cancer. 2000 Apr;82(7):1254-60. doi: 10.1054/bjoc.1999.1087. Br J Cancer. 2000. PMID: 10755397 Free PMC article. Clinical Trial.
Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cystostatic policy. Cooperative Group of Study and Treatment of Multiple Myeloma.
Riccardi A, Ucci G, Luoni R, Brugnatelli S, Mora O, Spanedda R, De Paoli A, Barbarano L, Di Stasi M, Alberio F, et al. Riccardi A, et al. Br J Cancer. 1994 Dec;70(6):1203-10. doi: 10.1038/bjc.1994.474. Br J Cancer. 1994. PMID: 7981078 Free PMC article. Clinical Trial.
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
Brugnatelli S, Riccardi A, Ucci G, Mora O, Barbarano L, Piva N, Piccinini L, Bergonzi C, De Paoli A, Di Stasi M, Rinaldi E, Trotti G, Petrini M, Ascari E. Brugnatelli S, et al. Among authors: riccardi a. Br J Cancer. 1996 Mar;73(6):794-7. doi: 10.1038/bjc.1996.138. Br J Cancer. 1996. PMID: 8611382 Free PMC article. Clinical Trial.
A prognostic index for multiple myeloma.
Grignani G, Gobbi PG, Formisano R, Pieresca C, Ucci G, Brugnatelli S, Riccardi A, Ascari E. Grignani G, et al. Among authors: riccardi a. Br J Cancer. 1996 May;73(9):1101-7. doi: 10.1038/bjc.1996.212. Br J Cancer. 1996. PMID: 8624271 Free PMC article. Clinical Trial.
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma.
Riccardi A, Mora O, Brugnatelli S, Tinelli C, Spanedda R, De Paoli A, Barbarano L, Di Stasi M, Bergonzi C, Giordano M, Delfini C, Nicoletti G, Rinaldi E, Piccinini L, Valentini D, Ascari E. Riccardi A, et al. Br J Cancer. 1998;77(3):485-91. doi: 10.1038/bjc.1998.77. Br J Cancer. 1998. PMID: 9472648 Free PMC article. Clinical Trial.
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer.
Riccardi A, Brugnatelli S, Giordano M, Danova M, Pugliese P, Tinelli C, Klersy C, Richetti A, Fava S, Nastasi G, Rinaldi E, Fregoni V, De Monte A, Trotti G, Bovio A, Ascari E. Riccardi A, et al. Tumori. 1998 Sep-Oct;84(5):540-6. doi: 10.1177/030089169808400506. Tumori. 1998. PMID: 9862513 Clinical Trial.
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01).
Riccardi A, Pugliese P, Danova M, Brugnatelli S, Grasso D, Giordano M, Bernardo G, Giardina G, Fava S, Montanari G, Pedrotti C, Trotti G, Rinaldi E, Poli MA, Tinelli C. Riccardi A, et al. Br J Cancer. 2001 Jul 20;85(2):141-6. doi: 10.1054/bjoc.2001.1897. Br J Cancer. 2001. PMID: 11461067 Free PMC article. Clinical Trial.
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.
Riccardi A, Mora O, Tinelli C, Porta C, Danova M, Brugnatelli S, Grasso D, Tolcà B, Spanedda R, De Paoli A, Barbarano L, Cavanna L, Giordano M, Delfini C, Nicoletti G, Bergonzi C, Rinaldi E, Piccinini L, Ascari E. Riccardi A, et al. Eur J Cancer. 2003 Jan;39(1):31-7. doi: 10.1016/s0959-8049(02)00529-4. Eur J Cancer. 2003. PMID: 12504655 Clinical Trial.
Multiple myeloma.
Ascari E, Merlini G, Riccardi A. Ascari E, et al. Among authors: riccardi a. Ann Ital Med Int. 1990 Jul-Sep;5(3 Pt 3):312-21. Ann Ital Med Int. 1990. PMID: 2081091 Review.
377 results